SBIR Phase I: Development of a Sterilization-based Reusable Catheterization System

SBIR 第一阶段：开发基于灭菌的可重复使用导尿系统

• 批准号: 2021595
• 负责人: Souvik Paul
• 金额: $ 25.6万
• 依托单位: CATHBUDDY, INC.
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-01 至 2021-07-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2021595&HistoricalAwards=false
• 关键词: SBIR; Phase; Development; Sterilization; based

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to improve the process of intermittent urinary catheterization while decreasing the risk of associated infection For individuals who cannot empty their bladder due to anatomic or physiologic causes, single-use intermittent catheterization is the safest method for bladder emptying. Despite this, typical catheterization methods produce an annual 40-60% risk of complicated urinary tract infection, leading to over $4 billion of avoidable healthcare costs and patient morbidity. Some catheterization tools are safer than standard disposable catheters (e.g. no-touch catheters), but these are more costly and rarely used. To address this cost, some individuals attempt to sterilize their single-use catheters and reuse them in an off-label manner, increasing the risk of urinary tract infection to 70-80% per year. This project aims to develop a safe reusable catheter with the benefits of a no-touch catheter, allowing for an at-home sterilization device; this innovation will allow for a decrease in urinary tract infection risk, improvement in catheter usability, decreased catheter spending, and a 99% reduction of catheter-associated waste.This Small Business Innovation Research (SBIR) Phase I project will focus on the technical sterilization abilities of this novel purpose-built catheter sterilization device, especially when dealing with anticipated formation of bacterial biofilms. This research will involve exposing catheter samples to pathogen-inoculated urine, performing the anticipated cleaning and sterilization methodologies, and utilizing previously-validated fluorescence imaging techniques to document the presence and location of surviving bacteria and biofilm formation. It is expected that the intended sterilization techniques inherent in this novel device will provide adequate sterilization assurance for safe catheter reuse. This project will also focus on the feasibility of the laboratory-validated cleaning and sterilization protocol for anticipated users to perform without medical supervision. This research will examine cleaning and sterilization protocols by individual catheter users to determine points of potential risk to inform design of the device and the protocol.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

这个小企业创新研究（SBIR）一期项目的更广泛的影响/商业潜力将是改进间歇导尿的过程，同时降低相关感染的风险。对于由于解剖或生理原因不能排尿的个体，一次性间歇导尿是排尿最安全的方法。尽管如此，典型的导尿方法每年产生40-60%的复杂性尿路感染风险，导致超过40亿美元的可避免医疗成本和患者发病率。一些置管工具比标准的一次性置管（如非接触式置管）更安全，但它们更昂贵且很少使用。为了解决这一成本问题，一些人试图对一次性导尿管进行消毒，并以非标签方式重复使用，这使尿路感染的风险每年增加到70-80%。该项目旨在开发一种安全的可重复使用的导管，具有非接触式导管的优点，允许家庭消毒装置；这一创新将降低尿路感染风险，提高导尿管可用性，减少导尿管费用，并减少99%的导尿管相关浪费。这项小型企业创新研究（SBIR）一期项目将重点研究这种新型专用导管灭菌装置的技术灭菌能力，特别是在处理预期形成的细菌生物膜时。这项研究将包括将导管样本暴露于接种了病原体的尿液中，执行预期的清洁和灭菌方法，并利用先前验证的荧光成像技术来记录存活细菌的存在和位置以及生物膜的形成。预计这种新型装置所固有的灭菌技术将为导管的安全再利用提供充分的灭菌保证。该项目还将侧重于实验室验证的清洁和灭菌方案的可行性，以便预期用户在没有医疗监督的情况下执行。本研究将检查单个导管使用者的清洁和灭菌方案，以确定潜在风险点，为设备和方案的设计提供信息。该奖项反映了美国国家科学基金会的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。